Pharmaceutical Chemistry · Short notes

Stereochemistry of Drugs: Short Notes & Cheat Sheet

Chirality, enantiomers and diastereomers, R/S and D/L naming, geometric isomers and why single enantiomers matter clinically.

Short notes

Read these before you attempt the topic's MCQs.

Kinds of stereoisomer

EnantiomersMirror images; same physicalpropertiesDiastereomersNot mirror images; differentpropertiesGeometric isomerscis/trans or E/Z; a type ofdiastereomerMeso compoundsChiral centres but opticallyinactiveRacemate50:50 mixture; optically inactiveConformersRotate about single bonds; notseparableStereoisomers
Start by asking: are the two structures mirror images? If yes they are enantiomers; if not, diastereomers.

Types of isomer

  • Enantiomers are non-superimposable mirror images. They have identical physical properties except the direction in which they rotate plane-polarised light, but can differ greatly in biological activity.
  • Diastereomers are stereoisomers that are not mirror images. They differ in physical properties (e.g. quinine and quinidine).
  • A racemic mixture (50:50 of two enantiomers) is optically inactive. A meso compound has chiral centres but an internal plane of symmetry, so it is also optically inactive (meso-tartaric acid).
  • A molecule with n chiral centres has up to 2ⁿ stereoisomers.
  • Geometric (cis/trans or E/Z) isomers need restricted rotation, around a double bond or in a ring.

Naming

  • R/S (Cahn–Ingold–Prelog): rank groups by atomic number, point the lowest away, and read 1 → 2 → 3. Clockwise is R, anticlockwise is S.
  • D/L relates configuration to glyceraldehyde (Fischer projection). Natural amino acids are L; natural sugars are D.
  • (+)/(−) or d/l describe the direction of optical rotation measured with a polarimeter. They have no fixed relationship to R/S or D/L.
  • Specific rotation is usually measured at 20 °C with the sodium D line (589 nm).

Why it matters in drugs

  • Receptors are chiral, so enantiomers often differ (three-point attachment, Easson–Stedman). The more active one is the eutomer; the less active is the distomer; their activity ratio is the eudismic ratio.
  • Thalidomide: one enantiomer is sedative and the other teratogenic, but they interconvert in the body, so giving a single enantiomer would not have prevented harm.
  • Only L-dopa is used (D-dopa is inactive and toxic). D-penicillamine is used because L-penicillamine is toxic.
  • Cisplatin's cis isomer is active; the trans isomer is not.
  • Ibuprofen's S-form is active, and the body converts much of the R-form into S.
  • Single-enantiomer drugs (chiral switches): esomeprazole, escitalopram, levocetirizine, levofloxacin, levosalbutamol, esketamine.

Cheat sheet

High-yield facts in one place. Cover the right-hand column and test yourself.

Enantiomer examples

DrugKey point
ThalidomideR sedative, S teratogenic; interconvert in vivo
LevodopaL-form only; D-form toxic
PenicillamineD-form used; L-form toxic
DextromethorphanAntitussive; its levo-isomer is an opioid (levorphanol)
IbuprofenS active; R converted to S
WarfarinS-warfarin 2–5× more potent
Quinine / quinidineDiastereomers: antimalarial / antiarrhythmic
CisplatinOnly the cis isomer is active

Naming systems

SystemBased on
R / SCIP priority rules (absolute configuration)
D / LComparison with glyceraldehyde
(+) / (−)Measured direction of optical rotation
E / ZCIP priorities across a double bond
cis / transSame or opposite side

Memory aids

R = Right turn (clockwise)
With the lowest-priority group pointing away, clockwise 1 → 2 → 3 is R.

Exam traps

  • An R compound is not necessarily dextrorotatory; R/S and (+)/(−) are unrelated.
  • Enantiomers have the same melting point and solubility; diastereomers do not.
  • Meso compounds contain chiral centres but are optically inactive.
  • Giving pure R-thalidomide would not have prevented birth defects, because it converts to S in the body.

Revised? Now test yourself.

Attempt the Stereochemistry of Drugs MCQs while the notes are fresh. Anything you get wrong is saved to your incorrect list for the next revision round.

More Pharmaceutical Chemistry notes